Search research articles
Contact Us
Filters
Showing results (41-50 of 77) with videos related to
Page
of 8
Sort By:
Spine
|
August 20, 2025
Current use and Complications Associated with Bone Morphogenetic Protein in Spine Fusion Surgery: A Review of 9809 Patients
Maximilian K Korsun, Tomoyuki Asada, Takashi Hirase, et al.
Spine
|
May 17, 2024
Morbidly Obese Patients Have Similar Clinical Outcomes and Recovery Kinetics After Minimally Invasive Decompression
Pratyush Shahi, Tejas Subramanian, Sumedha Singh, et al.
Spine
|
May 6, 2024
Temporal Trends of Improvement After Minimally Invasive Transforaminal Lumbar Interbody Fusion
Pratyush Shahi, Tejas Subramanian, Olivia Tuma, et al.
The Spine Journal : Official Journal of the North American Spine Society
|
June 7, 2024
Level-specific comparison of 3D navigated and robotic arm-guided screw placement: an accuracy assessment of 1210 pedicle screws in lumbar surgery
Tomoyuki Asada, Tejas Subramanian, Chad Z Simon, et al.
The Journal of Bone and Joint Surgery. American Volume
|
July 8, 2025
Incidence and Prediction of Postoperative Urinary Retention Following Lumbar Decompression
Cole Kwas, Eric Kim, Joshua Zhang, et al.
Spine
|
February 20, 2024
Limited Improvement With Minimally Invasive Lumbar Decompression Alone for Degenerative Scoliosis With Cobb Angle Over 20°: The Impact of Decompression Location
Tomoyuki Asada, Chad Z Simon, Nishtha Singh, et al.
Science Advances
|
June 7, 2024
Epigenetic predictors of species maximum life span and other life-history traits in mammals
Caesar Z Li, Amin Haghani, Qi Yan, et al.
European Urology
|
March 3, 2023
Disease-free Survival Analysis for Patients with High-risk Muscle-invasive Urothelial Carcinoma from the Randomized CheckMate 274 Trial by PD-L1 Combined Positive Score and Tumor Cell Score
Matthew D Galsky, Dean F Bajorin, Johannes Alfred Witjes, et al.
European Urology
|
January 4, 2024
Corrigendum to "Disease-free Survival Analysis for Patients with High-risk Muscle-invasive Urothelial Carcinoma from the Randomized CheckMate 274 Trial by PD-L1 Combined Positive Score and Tumor Cell Score" [Eur. Urol. 83(5) (2024) 432-440]
Matthew D Galsky, Dean F Bajorin, Johannes Alfred Witjes, et al.
The Lancet. Oncology
|
June 10, 2022
Nivolumab plus cabozantinib versus sunitinib in first-line treatment for advanced renal cell carcinoma (CheckMate 9ER): long-term follow-up results from an open-label, randomised, phase 3 trial
Robert J Motzer, Thomas Powles, Mauricio Burotto, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 77) with videos related to
Sort By:
Page
of 8
Spine
|
August 20, 2025
Current use and Complications Associated with Bone Morphogenetic Protein in Spine Fusion Surgery: A Review of 9809 Patients
Maximilian K Korsun, Tomoyuki Asada, Takashi Hirase, et al.
Spine
|
May 17, 2024
Morbidly Obese Patients Have Similar Clinical Outcomes and Recovery Kinetics After Minimally Invasive Decompression
Pratyush Shahi, Tejas Subramanian, Sumedha Singh, et al.
Spine
|
May 6, 2024
Temporal Trends of Improvement After Minimally Invasive Transforaminal Lumbar Interbody Fusion
Pratyush Shahi, Tejas Subramanian, Olivia Tuma, et al.
The Spine Journal : Official Journal of the North American Spine Society
|
June 7, 2024
Level-specific comparison of 3D navigated and robotic arm-guided screw placement: an accuracy assessment of 1210 pedicle screws in lumbar surgery
Tomoyuki Asada, Tejas Subramanian, Chad Z Simon, et al.
The Journal of Bone and Joint Surgery. American Volume
|
July 8, 2025
Incidence and Prediction of Postoperative Urinary Retention Following Lumbar Decompression
Cole Kwas, Eric Kim, Joshua Zhang, et al.
Spine
|
February 20, 2024
Limited Improvement With Minimally Invasive Lumbar Decompression Alone for Degenerative Scoliosis With Cobb Angle Over 20°: The Impact of Decompression Location
Tomoyuki Asada, Chad Z Simon, Nishtha Singh, et al.
Science Advances
|
June 7, 2024
Epigenetic predictors of species maximum life span and other life-history traits in mammals
Caesar Z Li, Amin Haghani, Qi Yan, et al.
European Urology
|
March 3, 2023
Disease-free Survival Analysis for Patients with High-risk Muscle-invasive Urothelial Carcinoma from the Randomized CheckMate 274 Trial by PD-L1 Combined Positive Score and Tumor Cell Score
Matthew D Galsky, Dean F Bajorin, Johannes Alfred Witjes, et al.
European Urology
|
January 4, 2024
Corrigendum to "Disease-free Survival Analysis for Patients with High-risk Muscle-invasive Urothelial Carcinoma from the Randomized CheckMate 274 Trial by PD-L1 Combined Positive Score and Tumor Cell Score" [Eur. Urol. 83(5) (2024) 432-440]
Matthew D Galsky, Dean F Bajorin, Johannes Alfred Witjes, et al.
The Lancet. Oncology
|
June 10, 2022
Nivolumab plus cabozantinib versus sunitinib in first-line treatment for advanced renal cell carcinoma (CheckMate 9ER): long-term follow-up results from an open-label, randomised, phase 3 trial
Robert J Motzer, Thomas Powles, Mauricio Burotto, et al.
Page
of 8